Back

Wearable defibrillator protected optimization of therapy and development of LVEF in newly diagnosed heart failure

1 May 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Chronic heart failure Chronic Ischaemic heart disease HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Herbert Naegele

Albertinen-Hospital, Hamburg (Germany)

84 More presentations in this session

Presentation thumbnail
Doctor J. Kewcharoen (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Doctor E. CHUQUIURE-VALENZUELA (Mexico City, MX)
Abstract
Presentation thumbnail
Doctor M. Al Qaseer (Dammam, SA)
Presentation thumbnail
Doctor C. Watson (Belfast, GB)
Abstract
Presentation thumbnail
Doctor E. Tahirovic (Berlin, DE)

Access the full session

Session thumbnail
Poster session 3 - Chronic heart failure

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Three-year trajectory of ventricular function recovery in newly diagnosed heart failure with reduced ejection fraction using a wearable cardioverter-defibrillator
14 April 2026
thumbnail
Webinar
New 2021 HF guidelines - what is new for device therapies and how to optimally combine new HF drugs with ICD-CRTDs
16 February 2023
thumbnail
Congress Presentation
In newly discovered HFrEF the wearable defibrillator is a valuable solution for preventing sudden death: pro
31 August 2026
thumbnail
Congress Presentation
The use of wearable cardioverter defibrillator in France
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources